Drugs / AV0113
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02533895 | Feb 2000 → Aug 2015 | childhood malignant neoplasm | Activartis Biotech | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AV0113 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02533895 ↗ |
| Modality | Cell therapy | “anti-tumour immune therapy with autologous Dendritic Cells (DCs) loaded with tumour cell lysates” NCT02533895 ↗ |
| Route | Other | “injected intra-nodally into tumour free lymph nodes or subcutaneously close to tumour free lymph nodes” NCT02533895 ↗ |
| Route | Subcutaneous | “injected intra-nodally into tumour free lymph nodes or subcutaneously close to tumour free lymph nodes” NCT02533895 ↗ |